Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/04/041627
CTRI/2022/04/041627
Not yet recruiting
Phase 2

â??Evaluation of clinical and microbiological effectiveness of gum astringent containing a combination of Neem, Tulsi, Almond, Fitkari, Green tea and Orange Satva in patients with biofilm induced-gingivitis as an adjunct to scaling: A randomized controlled clinical trial.�?

Purexa Global Pvt Ltd0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: K050- Acute gingivitis

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: K050- Acute gingivitis
Sponsor
Purexa Global Pvt Ltd
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Purexa Global Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • •1\.Patients agreeing to comply with study protocol and instructions
  • •2\.Subject should have at least 20 natural permanent teeth
  • •3\.Patient with dental biofilm induced gingivitis alone.
  • •4\.All subjects who are systemically healthy.
  • •5\.Subjects having Gingival index more than 1\.
  • •6\.At baseline, all the subjects had to have a plaque index of greater than 2\.

Exclusion Criteria

  • •1\.Smokers and tobacco chewer.
  • •2\.Patients on antibiotics one months prior to treatment.
  • •3\.Patients using orthodontic or prosthodontic appliances either fixed or removable
  • •4\.Patients who have used mouth rinse containing chemical agents in previous two months.
  • •5\.Patients allergic or sensitive to any medication or toothpaste.
  • •6\.History of any surgical procedure in the selected area in the past two months.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 3
Clinical and bacteriological Effects of Synbiotic as an Adjunct in Phase I Periodontal TherapyChronic periodontitis.Chronic periodontitisK05.3
IRCT20130216012487N7Esfahan University of Medical Sciences28
Not yet recruiting
Phase 2
Clinical and microbiological evaluation after treatment at the site of chronic periodontal disease, with gels containing antimicrobial agents
RBR-226f6jFaculdade De Odontologia de Ribeirão Preto
Active, not recruiting
Not Applicable
EVALUATION OF THE CLINICAL AND MICROBIOLOGICAL EFFICACY OF N-ACETILCISTEINA 600 MG, IN COMBINATION TO CEFPODOXIMA PROXETILE, IN THE THERAPY OF THE INFECTIONS OF THE HIGH RESPIRATORY WAYS IN ADULT PATIENTS CLINICAL STUDY MULTICENTRIC, TO GROUPS PARALLELS, DOUBLE - BLIND VS PLACEBO - NDInfection of the high respiratory ways in adult patientsMedDRA version: 9.1Level: HLTClassification code 10004054Term: Bacterial upper respiratory tract infections
EUCTR2007-000260-24-ITZAMBON ITALIA
Not yet recruiting
Not Applicable
Comparison of Efficacy of SRP Alone & in Combination with LDD & Mouthwash in patients with Periodontitis
CTRI/2023/07/055061SGT UNIVERSITY
Completed
Not Applicable
Evaluate the effect of probiotics and phase 1 of periodontal treatment on patient with moderate to severe periodontitischronic periodontitis.Chronic periodontitis
IRCT201201258825N1Dental research center, Tehran University of Medical Sciences20